Un Jung Kang, MD
H. Houston Merritt Professor of Neurology and Chief of the Movement Disorders Division at Columbia University
Location: New York, New York, United States
Un Jung Kang, MD, received his medical degree from the Johns Hopkins University and obtained his neurology residency and movement disorders fellowship training at Columbia University. He worked at the University of Chicago from 1992 to 2013 and moved back to Columbia in 2013.
His clinical expertise is in movement disorders including Parkinson’s disease (PD). Dr. Kang's research interests include understanding the mechanisms of both beneficial and detrimental effects of dopaminergic therapy such as dyskinesia. He is also interested in understanding the mechanisms of neurodegeneration by studying the genes associated with PD. Dr. Kang is interested in biomarker development in PD and leads a cohort of the MJFF-sponsored study The Fox Investigation for New Discovery of Biomarkers (BioFIND), and his laboratory is studying biological marker assays.
- White Blood Cell and Urine Collection in LRRK2 and GBA Mutation Carriers (2017)
- Development of a Biomarker Assay for Oxidized DJ-1 in Parkinson’s Disease (2014)
- Gene Expression Changes in Striatal Cholinergic Interneurons Associated with Levodopa-induced Dyskinesia (2014)
- Role of Striatal Cholinergic Interneurons in Parkinson’s Disease Dyskinesia (2014)
- Collaborative Validation of Oxidized DJ-1 Antibodies For PD Biomarker Study (2012)
- The Fox Investigation for New Discovery of Biomarkers (BioFIND) (2012)
- A Small Molecule Approach to Correct Striatal Cholinergic Interneuron Dysfunction (2012)
- Modulation of striatal cholinergic neuronal activity in LID (2011)
- Development of Highly Sensitive and Specific Antibodies Against Oxidized DJ-1 as a Biomarker for Parkinson's Disease (2011)
- Oxidized DJ-1 as a biomarker for Parkinson's disease (2010)